Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (BMEA)

CUSIP: 09077A106

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
79,264,970
Total 13F shares
23,418,825
Share change
-7,750,433
Total reported value
$105,385,983
Put/Call ratio
29%
Price per share
$4.50
Number of holders
103
Value change
-$56,287,309
Number of buys
59
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 09077A106?
CUSIP 09077A106 identifies BMEA - Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BMEA - Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
6.8%
5,355,867
$80,070,212 31 Mar 2024
13F
STATE STREET CORP
13F
Company
5.7%
4,485,615
$67,059,944 31 Mar 2024
13F
Cormorant Asset Management, LP
13F
Company
4.5%
3,570,872
$53,384,536 31 Mar 2024
13F
Laurion Capital Management LP
13F
Company
3.4%
2,720,983
$40,678,696 31 Mar 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
2.7%
2,108,949
$31,528,788 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
2.5%
1,973,500
$29,503,826 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
1.7%
1,365,625
$20,416,094 31 Mar 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.6%
1,285,278
$19,213,770 31 Mar 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.5%
1,193,953
$17,849,597 31 Mar 2024
13F
Sotirios Stergiopoulos
3/4/5
Director
class O/S missing
4,400,000
$16,643,000 17 Sep 2021
A2A Pharmaceuticals, Inc.
3/4/5
10%+ Owner
class O/S missing
3,500,000
$13,238,750 31 May 2023
Aisling Capital Management LP
13F
Company
1%
798,757
$11,941,417 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.62%
493,631
$7,381,060 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.6%
478,367
$7,151,587 31 Mar 2024
13F
Woodline Partners LP
13F
Company
0.59%
464,573
$6,945,366 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.58%
457,421
$6,838,454 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.52%
409,558
$6,122,892 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.44%
347,964
$5,202,062 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.39%
305,953
$4,573,997 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.36%
287,864
$4,303,567 31 Mar 2024
13F
UBS Group AG
13F
Company
0.33%
264,199
$3,949,775 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.27%
216,444
$3,235,838 31 Mar 2024
13F
Rock Springs Capital Management LP
13F
Company
0.23%
181,147
$2,708,148 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.23%
178,935
$2,675,078 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.22%
177,602
$2,656,000 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.22%
171,763
$2,567,856 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.13%
102,534
$1,532,884 31 Mar 2024
13F
Sculptor Capital LP
13F
Company
0.12%
95,100
$1,421,745 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.11%
89,865
$1,343,482 31 Mar 2024
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.1%
76,285
$1,140,461 31 Mar 2024
13F
Prosight Management, LP
13F
Company
0.09%
75,000
$1,121,250 31 Mar 2024
13F
PROFUND ADVISORS LLC
13F
Company
0.09%
72,877
$1,089,511 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.08%
63,917
$955,563 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
59,787
$893,816 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.07%
55,184
$825,002 31 Mar 2024
13F
LPL Financial LLC
13F
Company
0.07%
54,469
$814,312 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
53,546
$800,513 31 Mar 2024
13F
WEXFORD CAPITAL LP
13F
Company
0.06%
47,279
$706,821 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.06%
46,817
$699,915 31 Mar 2024
13F
Swiss National Bank
13F
Company
0.06%
45,700
$683,215 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.05%
42,572
$636,452 31 Mar 2024
13F
Nan Fung Group Holdings Ltd
13F
Company
0.05%
40,000
$598,000 31 Mar 2024
13F
GRIFFIN ASSET MANAGEMENT, INC.
13F
Company
0.05%
37,890
$566,455 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
36,218
$541,459 31 Mar 2024
13F
Artia Global Partners LP
13F
Company
0.04%
35,452
$530,007 31 Mar 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.04%
35,444
$530,000 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.04%
33,401
$499,345 31 Mar 2024
13F
SG Americas Securities, LLC
13F
Company
0.04%
30,924
$462,000 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.04%
30,748
$459,683 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
29,140
$435,643 31 Mar 2024
13F

Institutional Holders of Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (BMEA) as of Q2 2024

As of 30 Jun 2024, Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (BMEA) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,418,825 shares. The largest 10 holders included FMR LLC, Cormorant Asset Management, LP, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Aisling Capital Management LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 105 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
103
Q2 2024 holders
103
Holder diff
0
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .